tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market

JW (Cayman) Therapeutics Co. Ltd. (2126) Income Statement

Compare
0 Followers

JW (Cayman) Therapeutics Co. Ltd. Income Statement

Last quarter (Q2 2024), JW (Cayman) Therapeutics Co. Ltd.'s total revenue was ¥86.81M, an increase of 31.52% from the same quarter last year. In Q2, JW (Cayman) Therapeutics Co. Ltd.'s net income was ¥-240.27M. See JW (Cayman) Therapeutics Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 173.86M¥ 145.70M¥ 30.80M¥ 0.00¥ 5.48M
Gross Profit
¥ 88.22M¥ 58.76M¥ 9.04M¥ 0.00¥ 5.48M
Operating Expenses
¥ 877.83M¥ 914.64M¥ 716.98M¥ 1.67B¥ 639.21M
Depreciation and Amortization
¥ 99.83M¥ 87.07M¥ 48.23M¥ 13.82M¥ 9.11M
EBITDA
¥ -655.75M¥ -752.27M¥ -738.70M¥ -454.04M¥ -194.40M
Operating Income
¥ -789.61M¥ -697.17M¥ -771.72M¥ -467.86M¥ -203.52M
Other Income/Expenses
¥ 21.61M¥ 9.75M¥ 56.76M¥ -1.20B¥ -429.74M
Pretax Income
¥ -768.00M¥ -846.13M¥ -702.33M¥ -1.66B¥ -633.26M
Net Income
¥ -768.00M¥ -846.13M¥ -702.33M¥ -1.66B¥ -633.26M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -1.87¥ -2.06¥ -1.76¥ -12.61¥ -9.74
Diluted EPS
¥ -1.87¥ -2.06¥ -1.76¥ -12.61¥ -9.74
Weighted Average Shares Outstanding
411.53M 410.09M 399.75M 131.90M 65.00M
Weighted Average Shares Outstanding (Diluted)
411.53M 410.09M 399.75M 131.90M 65.00M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis